SRT-100™: A Painless, Non-Invasive, Non-Melanoma Skin Cancer Treatment Right in Your Office
Whether you are a radiation oncologist or a dermatologist, you can enhance your patient care with the SRT-100™ non-melanoma skin cancer treatment.
SRT-100™: A Non-Melanoma Skin Cancer Treatment Your Body Can Handle, but Cancer Cannot
Skin cancer is the fastest growing cancer in the world. Experts predict the number of people diagnosed with non-melanoma skin cancer will grow to nearly six million by the year 2020. With the epidemic of basal and squamous cell skin cancer diagnosis follows the common and less than ideal solution of surgical non-melanoma skin cancer […]
Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award
– Sensus Credited with Advancing Superficial Radio Therapy as Viable Treatment Option for NMSC – BOCA RATON, Fla., Sept. 7, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today it […]
